285,819 Shares in Option Care Health, Inc. (NASDAQ:OPCH) Bought by Susquehanna Fundamental Investments LLC

Susquehanna Fundamental Investments LLC purchased a new position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 285,819 shares of the company's stock, valued at approximately $6,631,000. Susquehanna Fundamental Investments LLC owned approximately 0.17% of Option Care Health as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. JPMorgan Chase & Co. raised its stake in Option Care Health by 29.6% in the fourth quarter. JPMorgan Chase & Co. now owns 1,511,403 shares of the company's stock valued at $35,065,000 after buying an additional 344,875 shares in the last quarter. Graypoint LLC purchased a new position in shares of Option Care Health in the 4th quarter valued at about $1,161,000. Charles Schwab Investment Management Inc. raised its position in shares of Option Care Health by 6.2% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,510,131 shares of the company's stock worth $58,235,000 after acquiring an additional 147,054 shares in the last quarter. Global Alpha Capital Management Ltd. lifted its stake in Option Care Health by 38.1% during the fourth quarter. Global Alpha Capital Management Ltd. now owns 68,810 shares of the company's stock worth $1,596,000 after purchasing an additional 18,992 shares during the last quarter. Finally, Y Intercept Hong Kong Ltd acquired a new position in Option Care Health in the fourth quarter valued at approximately $327,000. 98.05% of the stock is owned by hedge funds and other institutional investors.

Option Care Health Stock Performance

Option Care Health stock traded down $0.14 during trading hours on Thursday, reaching $32.17. 3,984,063 shares of the stock were exchanged, compared to its average volume of 1,818,627. The stock has a market cap of $5.28 billion, a P/E ratio of 27.03, a P/E/G ratio of 2.30 and a beta of 1.07. The firm's 50 day moving average is $33.34 and its 200 day moving average is $28.82. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $35.53.

Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.36 by $0.04. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. The firm had revenue of $1.33 billion during the quarter, compared to analysts' expectations of $1.26 billion. During the same period in the prior year, the company posted $0.26 earnings per share. The firm's revenue for the quarter was up 16.3% on a year-over-year basis. Analysts predict that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

Insider Activity at Option Care Health

In other news, insider Michael Bavaro sold 30,996 shares of the company's stock in a transaction on Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the transaction, the insider now directly owns 44,974 shares of the company's stock, valued at $1,495,835.24. This represents a 40.80 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 0.64% of the company's stock.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on the stock. JMP Securities restated a "market outperform" rating and set a $36.00 price objective on shares of Option Care Health in a research report on Tuesday, April 22nd. UBS Group upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and upped their price objective for the company from $38.00 to $40.00 in a research note on Wednesday. Barrington Research reiterated an "outperform" rating and set a $38.00 target price on shares of Option Care Health in a research report on Wednesday. Jefferies Financial Group raised Option Care Health from a "hold" rating to a "buy" rating and upped their target price for the company from $26.00 to $35.00 in a research report on Thursday, January 23rd. Finally, JPMorgan Chase & Co. lifted their price target on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research report on Thursday, March 6th. One investment analyst has rated the stock with a hold rating and seven have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $35.50.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.